| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.009 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.093 | 0.009 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.02 |